NCT03968991|Terminated
Study Stopped
low recruits
VISIODOL: Validation of the VISIODOL® Scale
VISIODOL
Loading search results
low recruits
VISIODOL
Sponsor study identifier
Secondary identifiers
OTHER · 2018-A03370-55
interventional
37
1 country
1
Study Start
June 18, 2019
Actual (reported)Primary Completion
December 28, 2020
Actual (reported)Study Completion
December 28, 2020
Actual (reported)The aim of this study is to validate the VISIODOL® scale for screening of pain in people with visual impairment.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 28, 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 29, 2019
Actual (reported)May 31, 2019
Actual (reported)June 18, 2019
Actual (reported)December 28, 2020
Actual (reported)December 28, 2020
Actual (reported)Validation of the VISIODOL® scale in screening of pain in people with visual impairment using the correlation coefficient between the intensities measured with the Numerical Scale (NS) and the VISIODOL® scale obtained by using thermal tests.
Determination of the correlation coefficient between NS and VISIODOL® scale for different pain temperatures by hot thermal tests. The rating of the NS and VISIODOL® scales can range from 0 to 10.
Day 0 + 2 hours
Validation of the VISIODOL® scale in screening of pain in people with visual impairment using the correlation coefficient between the intensities measured with the Numerical Scale (NS) and the VISIODOL® scale obtained by using thermal tests.
Day 0 + 2 hours
Validation of the VISIODOL® scale in screening of pain in people with visual impairment using the correlation coefficient between the intensities measured with the Numerical Scale (NS) and the VISIODOL® scale obtained by using thermal tests .
Day 0 + 2 hours
Validation of the VISIODOL® scale in screening of pain in people with visual impairment using the correlation coefficient between the intensities measured with the Numerical Scale (NS) and the VISIODOL® scale obtained by using thermal tests.
Day 0 + 2 hours
Validation of the VISIODOL® scale in screening of pain in people with visual impairment using the correlation coefficient between the intensities measured with the Numerical Scale (NS) and the VISIODOL® scale obtained by using mechanical tests.
Day 0 + 2 hours
Validation of the VISIODOL® scale in screening of pain in people with visual impairment using the correlation coefficient between the intensities measured with the Numerical Scale (NS) and the VISIODOL® scale obtained by using mechanical tests.
male or female healthy volunteers
visual acquired disability
Visual congenital disability
Tool for assessing pain in the blind subject (with congenital or acquired deficiency)
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Chu Clermont Ferrand
Clermont-Ferrand, 63003, France
Pickering G, Morel V, Goubayon J, Touron A, Leray V, Pereira B. A tactile pain evaluation scale for persons with visual deficiencies. Pain Med. 2023 Jul 5;24(7):855-861. doi: 10.1093/pm/pnad013.
Gisèle Pickering
University Hospital, Clermont-Ferrand
37 participants (actual enrollment reported by the registry).
First Submitted
April 29, 2019
First Posted
May 31, 2019
Study Start
June 18, 2019
Actual (reported)Implantable Intraocular Pressure Sensor for Glaucoma Monitoring in Patients With Boston Keratoprosthesis Type 1
Day 0 + 2 hours
Contact the study team to confirm eligibility.
Primary Completion
December 28, 2020
Actual (reported)Study Completion
December 28, 2020
Actual (reported)Last Updated
August 7, 2026
Record last verified: 2026-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: